NLRP3 and cardiac hypertrophy: The NLRP3 inflammasome, according to another report, could be upregulated and activated in the cardiac hypertrophy models, which aggravates cardiac fibrosis through activating the TGF-β/Smad pathway and promotes cardiac hypertrophy through activating the MAPK pathway (Pan et al., 2019).